Concepedia

An international multidisciplinary consensus statement on MAFLD and the risk of CVD

Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, Virend K. Somers, Seung Up Kim, C. Anwar A. Chahal, Vincent Wai‐Sun Wong, Jingjing Cai, Michael D. Shapiro, Mohammed Eslam,

Hepatology International · 2023 · 183 citations · 79 references

DOIFull text

Open access

Concepts

References

79

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Journal of Hepatology · 2016 · 4.8K citations

, , +9

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Eduardo Vilar‐Gómez, Yadina Martínez-Pérez, Luis Calzadilla Bertot et al. · Gastroenterology · 2015 · 2.4K citations · Full text

, , +11

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal et al. · The Lancet · 2015 · 2.1K citations · Full text

, , +5

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

, , +16

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

Renata Belfort, Stephen A. Harrison, Kenneth Brown et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

, , +13